GAPNA is a name chosen to reflect the diversity of our current and potential members, all who are interested in providing the highest quality of care to older adults.

We are the only advanced practice nursing organization that focuses on older adults, the fastest growing segment of the population.

View complete details about the GAPNA Strategic Partners Program.

If you would like to discuss your involvement and more details, please contact Miriam I. Martin, Marketing Specialist, at 856-256-2374.

GAPNA thanks our Strategic Partners for their support of our organization.

Platinum Strategic Partners


ACADIA Pharmaceuticals
12830 El Camino Real
Suite 400
San Diego, CA 92130

As a leader in developing and commercializing innovative therapies for central nervous system disorders ACADIA Pharmaceuticals is committed to improving the lives of patients..


6611 Tributary Street, Suite 1
Baltimore, MD  21224

At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.

Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at and follow us on Twitter and LinkedIn.


508 Carnegie Center Dr,
Princeton, NJ 08540

We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.

Gold Strategic Partners

Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc.
12780 El Camino Real
San Diego, CA 92130

Neurology and Endocrinology Research and Therapy | Neurocrine Biosciences

Neurocrine discovers and develops pharmaceutical through its R&D platform, focused on neurological and endocrine based diseases and disorders. Learn more.


2440 Research Blvd
Rockville, MD 20850

PsychU is a community and comprehensive resource library for mental health. Our over 73,000 members share one simple belief: Enhanced information, increased collaboration, and ongoing discussion will lead to improved mental health care and patient outcomes for individuals with mental illnesses. Access thousands of mental health resources, webinars, live events and more, for free! Join us in improving mental health care… together.

Urovant Sciences, Inc.

Urovant Sciences
5281 California Avenue
Irvine, CA 92617

Urovant Sciences is a biopharmaceutical company focused on developing and commercializing therapies for patients. Urovant Sciences, a subsidiary of Sumitomo Pharma Co., Ltd., intends to develop treatments for additional diseases. Learn more about us at

Strategic Partners


1 DNA Way
South San Francisco, CA 94080

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.


84 Waterford Drive
Marlborough, MA  01752

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious neuropsychiatric conditions. Sunovion’s Long-Term Care team works to support a patient- and caregiver-centric approach across the post-acute continuum of care at all sites of care.

This process includes matching the customers Population Health Goals with our Therapeutic Portfolio and other resources to improve the quality of life for the populations we serve. Our ultimate objective is to always be a “Trusted Partner in Post-Acute and Long-Term Care.”

Learn more at and connect with us.

LinkedIn | Facebook | Twitter | YouTube


Xeris Pharmaceuticals, Inc.
180 N. Lasalle Street, Suite 1600
Chicago, IL  60601


Xeris Pharmaceuticals, Inc., the maker of Gvoke Hypopen®, is dedicated to unlocking the potential of glucagon. We believe that easier-to-use medicines can have a profound impact on the lives of patients and their families. That is why our first products to market are liquid glucagon, but that is just the beginning. We are also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue advancements that have the potential to change lives. Get to know us and see how our technology is unlocking the potential of today’s medicines at